Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders

AN Brandebura, A Paumier, TS Onur… - Nature Reviews …, 2023 - nature.com
There is increasing appreciation that non-neuronal cells contribute to the initiation,
progression and pathology of diverse neurodegenerative disorders. This Review focuses on …

Astrocytes in Alzheimer's disease: pathological significance and molecular pathways

P Preman, M Alfonso-Triguero, E Alberdi… - Cells, 2021 - mdpi.com
Astrocytes perform a wide variety of essential functions defining normal operation of the
nervous system and are active contributors to the pathogenesis of neurodegenerative …

Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease

S Morabito, E Miyoshi, N Michael, S Shahin… - Nature …, 2021 - nature.com
The gene-regulatory landscape of the brain is highly dynamic in health and disease,
coordinating a menagerie of biological processes across distinct cell types. Here, we …

hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data

S Morabito, F Reese, N Rahimzadeh, E Miyoshi… - Cell reports …, 2023 - cell.com
Biological systems are immensely complex, organized into a multi-scale hierarchy of
functional units based on tightly regulated interactions between distinct molecules, cells …

[HTML][HTML] Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration

TE Tracy, J Madero-Pérez, DL Swaney, TS Chang… - Cell, 2022 - cell.com
Tau (MAPT) drives neuronal dysfunction in Alzheimer disease (AD) and other tauopathies.
To dissect the underlying mechanisms, we combined an engineered ascorbic acid …

Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and …

ECB Johnson, EB Dammer, DM Duong, L Ping… - Nature medicine, 2020 - nature.com
Our understanding of Alzheimer's disease (AD) pathophysiology remains incomplete. Here
we used quantitative mass spectrometry and coexpression network analysis to conduct the …

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease

L Higginbotham, L Ping, EB Dammer, DM Duong… - Science …, 2020 - science.org
Alzheimer's disease (AD) lacks protein biomarkers reflective of its diverse underlying
pathophysiology, hindering diagnostic and therapeutic advancements. Here, we used …

Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease

Y Yang, V Tapias, D Acosta, H Xu, H Chen… - Nature …, 2022 - nature.com
Abnormalities in brain glucose metabolism and accumulation of abnormal protein deposits
called plaques and tangles are neuropathological hallmarks of Alzheimer's disease (AD) …

Functional regulatory variants implicate distinct transcriptional networks in dementia

YA Cooper, N Teyssier, NM Dräger, Q Guo, JE Davis… - Science, 2022 - science.org
Predicting the function of noncoding variation is a major challenge in modern genetics. In
this study, we used massively parallel reporter assays to screen 5706 variants identified …

Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau

S Rayaprolu, L Higginbotham, P Bagchi… - …, 2021 - nature.com
The repeated failures of amyloid-targeting therapies have challenged our narrow
understanding of Alzheimer's disease (AD) pathogenesis and inspired wide-ranging …